XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Impact of adoption
Preferred Stock
Common Stock
Additional Paid-In Capital
Treasury Stock
Retained Earnings / (Accumulated Deficit)
Retained Earnings / (Accumulated Deficit)
Impact of adoption
Balance (in shares) at Dec. 31, 2018     0 48,103,000        
Balance at Dec. 31, 2018 $ 277,589 $ 37 $ 0 $ 481 $ 341,139   $ (64,031) $ 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       147,000        
Common stock issued in connection with equity-based plans 1,591     $ 1 1,590      
Vesting of common stock subject to repurchase 2       2      
Stock-based compensation expense 4,267       4,267      
Net income attributable to common stockholders 9,010           9,010  
Balance (in shares) at Mar. 31, 2019     0 48,250,000        
Balance at Mar. 31, 2019 $ 292,496   $ 0 $ 482 346,998   (54,984)  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member              
Balance (in shares) at Dec. 31, 2018     0 48,103,000        
Balance at Dec. 31, 2018 $ 277,589 37 $ 0 $ 481 341,139   (64,031) 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Purchases of treasury stock (in shares) 0              
Net income attributable to common stockholders $ 22,806              
Balance (in shares) at Jun. 30, 2019     0 48,482,000        
Balance at Jun. 30, 2019 312,428   $ 0 $ 485 353,131   (41,188)  
Balance (in shares) at Mar. 31, 2019     0 48,250,000        
Balance at Mar. 31, 2019 292,496   $ 0 $ 482 346,998   (54,984)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       232,000        
Common stock issued in connection with equity-based plans 701     $ 3 698      
Vesting of common stock subject to repurchase $ 2       2      
Purchases of treasury stock (in shares) 0              
Stock-based compensation expense $ 5,433       5,433      
Net income attributable to common stockholders 13,796           13,796  
Balance (in shares) at Jun. 30, 2019     0 48,482,000        
Balance at Jun. 30, 2019 $ 312,428   $ 0 $ 485 353,131   (41,188)  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Beginning balance at Dec. 31, 2019 $ 11,210              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income / (loss) attributable to common stockholders (236)              
Ending balance at Mar. 31, 2020 10,974              
Balance (in shares) at Dec. 31, 2019     0 48,701,000   0    
Balance at Dec. 31, 2019 355,651 (816) $ 0 $ 487 365,627 $ 0 (10,463) (816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       107,000        
Common stock issued in connection with equity-based plans $ 1,365     $ 1 1,364      
Purchases of treasury stock (in shares) 147,153         147,000    
Purchases of treasury stock $ (5,149)         $ (5,149)    
Stock-based compensation expense 6,358       6,358      
Net income attributable to common stockholders 8,807           8,807  
Balance (in shares) at Mar. 31, 2020     0 48,808,000   (147,000)    
Balance at Mar. 31, 2020 $ 366,216   $ 0 $ 488 373,349 $ (5,149) (2,472)  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Beginning balance at Dec. 31, 2019 $ 11,210              
Ending balance at Jun. 30, 2020 10,716              
Balance (in shares) at Dec. 31, 2019     0 48,701,000   0    
Balance at Dec. 31, 2019 355,651 $ (816) $ 0 $ 487 365,627 $ 0 (10,463) $ (816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to common stockholders 25,802              
Balance (in shares) at Jun. 30, 2020     0 49,071,000   (147,000)    
Balance at Jun. 30, 2020 393,253   $ 0 $ 491 383,388 $ (5,149) 14,523  
Beginning balance at Mar. 31, 2020 10,974              
Increase (Decrease) in Temporary Equity [Roll Forward]                
Net income / (loss) attributable to common stockholders (370)              
Accretion adjustments of redeemable noncontrolling interest to redemption value 112              
Ending balance at Jun. 30, 2020 10,716              
Balance (in shares) at Mar. 31, 2020     0 48,808,000   (147,000)    
Balance at Mar. 31, 2020 366,216   $ 0 $ 488 373,349 $ (5,149) (2,472)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued in connection with equity-based plans (in shares)       263,000        
Common stock issued in connection with equity-based plans $ 3,059     $ 3 3,056      
Purchases of treasury stock (in shares) 0              
Stock-based compensation expense $ 7,095       7,095      
Accretion adjustments of redeemable noncontrolling interest to redemption value (112)       (112)      
Net income attributable to common stockholders 16,995           16,995  
Balance (in shares) at Jun. 30, 2020     0 49,071,000   (147,000)    
Balance at Jun. 30, 2020 $ 393,253   $ 0 $ 491 $ 383,388 $ (5,149) $ 14,523